TFRC and renal cell carcinoma: Staining for iron and TfR1 protein in renal epithelium, in addition to other iron metabolism proteins, thus warrants future study for the clinical risk stratification of RCC nephrectomy patients [e.g., patients with clinically localized RCC considering adjuvant drug therapy (134)], as do the enigmatic mechanisms underlying their intriguing prognostic impact.